The specific inhibitor of Hsp90, 17-allylamino-17-demethoxygeldanamycin (17-AAG), prevents the nuclear localization of androgen receptor in AI tumor at much lower doses than that required to inhibit androgen induced nuclear import of androgen receptors (AR) (13). The gene discussed is HSP90AA1; the disease is neoplasm.